يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Arriba MDC"', وقت الاستعلام: 1.36s تنقيح النتائج
  1. 1

    المصدر: Genes
    r-CIPF: Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
    Centro de Investigación Principe Felipe (CIPF)
    r-FISABIO. Repositorio Institucional de Producción Científica
    instname
    r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)

  2. 2
    دورية أكاديمية

    المؤلفون: de Arriba MDC; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Fernández G; Aptus Biotech SL, Madrid, Spain., Chacón-Solano E; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Mataix M; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Martínez-Santamaría L; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Illera N; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Carrión-Marchante R; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Martín ME; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Larcher F; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., González VM; Aptus Biotech SL, Madrid, Spain; Aptamer Group, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain., Del Río M; Department of Bioengineering and Aerospace, University Carlos III of Madrid, Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain., Carretero M; Centre for Biomedical Network Research on Rare Diseases (CIBERER), CB06/07/0019, ISCIII, Madrid, Spain; Biomedical Research Institute Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; Epithelial Biomedicine Division, Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain. Electronic address: marta.carretero@ciemat.es.

    المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2022 Aug; Vol. 142 (8), pp. 2238-2248.e8. Date of Electronic Publication: 2022 Jan 01.

    نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

  3. 3
    دورية أكاديمية

    المؤلفون: Martínez-Santamaría L; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Maseda R; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., de Arriba MDC; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Membrilla JA; Departamento de Neurología, Hospital Universitario La Paz, Madrid, Spain., Sigüenza AI; Servicio de Urgencias, Hospital Universitario La Paz, Madrid, Spain., Mascías J; Departamento de Neurología, Hospital Universitario La Paz, Madrid, Spain., García M; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Quintana L; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Esteban-Rodríguez I; Departamento de Patología, Hospital Universitario La Paz, Madrid, Spain., Hernández-Fernández CP; Departamento de Dermatología, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Illera N; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Duarte B; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Guerrero-Aspizúa S; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Woodley DT; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California., Del Río M, de Lucas R; Departamento de Dermatología, Hospital Universitario La Paz, Madrid, Spain., Larcher F; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain., Escámez MJ; Universidad Carlos III de Madrid, Departamento de Bioingeniería e Ingeniería Aeroespacial (UC3M), División de Biomedicina Epitelial, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII (CIBERER-ISCIII) - IIS-FJD, Madrid, Spain.

    المصدر: JAMA dermatology [JAMA Dermatol] 2022 Apr 01; Vol. 158 (4), pp. 439-443.

    نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

    بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

    SCR Disease Name: Epidermolysa bullosa simplex and limb girdle muscular dystrophy

  4. 4
    تقرير

    المؤلفون: Maseda R; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Martínez-Santamaría L; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Sacedón R; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Butta N; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., de Arriba MDC; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., García-Barcenilla S; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., García M; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Illera N; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Pérez-Conde I; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Carretero M; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., Jiménez E; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Melen G; Cell & Gene Therapies Laboratory, Niño Jesus University Hospital, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, School of Medicine, La Paz University Hospital, IdiPAZ, Autonomous University of Madrid, Madrid, Spain., Jiménez-Yuste V; Hematology Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain., Vicente Á; Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain., Del Río M; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain., de Lucas R; Department of Dermatology, La Paz University Hospital, Madrid, Spain., Escámez MJ; Department of Bioengineering, Carlos III University (UC3M), Madrid, Spain.; Rare Diseases Networking Biomedical Research Centre (CIBERER) U714, Madrid, Spain.; Regenerative Medicine and Tissue Engineering Group, Health Research Institute Foundation of the Jiménez Díaz Foundation, Madrid, Spain.; Centre for Energy, Environment and Technology Research (CIEMAT), Madrid, Spain.

    المصدر: Frontiers in medicine [Front Med (Lausanne)] 2020 Nov 26; Vol. 7, pp. 576558. Date of Electronic Publication: 2020 Nov 26 (Print Publication: 2020).

    نوع المنشور: Case Reports

    بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE